Date Range
Date Range
Date Range
GLOBAL DOMAIN PRIVACY
Via Zanchi 22
Bergamo, 24126
IT
GLOBAL DOMAIN PRIVACY
Global Domain Privacy
Via Zanchi 22
Bergamo, 24126
IT
The feed-use amino acids market pioneer. Has produced and sold L-Lysine. In 2009, AJINOMOTO EUROLYSINE S. Is again the first to launch the production of L-Valine. Our amino acids are produced by the fermentation of raw materials from agriculture such as beet sugar, beet molasses or starch hydrolysates from cereals.
Produit et commercialise de la L-Lysine. Depuis 1976, de la L-Thréonine. Depuis 1987 et du L-Tryptophane. Est une fois encore en 2009, le premier à lancer la production de L-Valine. Le premier des acides aminés.
定期お届けコース のご注文なら4,000円 税込 以上で.
Ajinomoto Pharmaceuticals and Kissei announce partnership for joint development and marketing. Of AJM300 and AJG511 for treatment of ulcerative colitis in Japan. EISAI AND AJINOMOTO PHARMACEUTICALS LAUNCH BRANCHED-CHAIN AMINO ACID FORMULA LIVAMIN. ORAL GRANULES IN THE PHILIPPINES. Phase 2a Clinical Study Data of AJM300,an Oral α4 Integrin Antagonist, in Ulcerative Colitis Presented in Digestive Disease Week 2014. Phase 2a Clinical Study Data of AJM300,.